Prenatal Testing and Newborn Screening Market Size worth USD 10.85 Billion by 2027 | Industry Trend –Rising Demand for Non-Invasive Techniques

The global prenatal testing and newborn screening market is projected to be worth USD 10.85 Billion by 2027, according to a current analysis by Emergen Research.

The global prenatal testing and newborn screening market is projected to be worth USD 10.85 Billion by 2027, according to a current analysis by Emergen Research. The prenatal testing and newborn screening market is observing high demand attributed to its increasing application in detecting fetal chromosome defects. Prenatal testing is considered superior to other screening modalities, particularly for trisomy 21 (one of the most prevalent congenital anomalies). Prenatal testing enables individuals to make informed decisions as to whether diagnostic testing should be carried out. Associated fetal chromosomal anomalies typically include the benefit or lack of genetic material that can differ from small segments to small segments of chromosomes to entire chromosomes.

The increasing popularity among pregnant women as an alternative to amniocentesis and awareness of genetic problems in the fetus and newborn babies drives prenatal testing and newborn screening market.

Claim Your FREE Sample Copy with Table of content@

However, the lack of awareness about prenatal testing and genetic disorder screening in newborns across the world is projected to impede the growth of the industry over the projected timeframe.

Key Highlights from the Report:

  • The ultrasonography sub-segment is projected to expand at an exponential growth rate during the projected timeframe. The growth is driven by the enhanced ability of the ultrasound diagnosis to efficiently screen and detect abnormalities in the baby’s position and action in the womb.
  • The non-invasive testing sub-segment is gaining traction owing to its significant advantages for pregnant women such as the diminished risk of miscarriage and lesser complications in infants. The non-invasive testing sub-segment is predicted to register the fastest CAGR of 13.3% during the projected timeframe attributable to the escalating prevalence of genetic disorders such as Down syndrome, Edward Syndrome, and other genetic aberrations related to trisomy.
  • The hospital sub-segment accounted for a substantial share of the industry in 2019 owing to the increasing implementation of non-invasive prenatal testing, availability of skilled healthcare professionals, escalating advancement in newborn screening technologies, and a better reimbursement policy scenario.
  • North America held the leading share of the market in 2019 and is foreseen to retain its leading position in the forthcoming years owing to the increasing availability of state-of-the-art and technologically equipped healthcare research system and advancements in whole-genome sequencing technologies.
  • Asia Pacific market is poised to witness a rapid expansion in the estimated timeline owing to the increasing advancement in next-generation sequencing (NGS) technologies, rapidly developing healthcare infrastructure, and increased R&D activities in developing economies of APAC.
  • Major companies operating in the industry include CRISPR, Abbott Laboratories, Color Genomics, Edinburgh Genomics, Bio-Rad Laboratories, Qiagen NV, Agilent Technologies, Editas Medicine, Illumina Inc., and Eurofins Scientific, among others.
  • Progenity, Inc., in 2019, announced the introduction of Resura Prenatal Test. The test is a non-invasive and personalized prenatal testing that screens efficiently for monogenetic disorders.

Check Our Prices@

For the purpose of this report, Emergen Research has segmented the Global Prenatal Testing and Newborn Screening Market on the basis of type, test type, technology, end-user, instruments, and region:

Type Outlook (Revenue, USD Billion; 2017-2027)

  • Newborn Screening
  • Prenatal Testing

Test Type Outlook (Revenue, USD Billion; 2017-2027)

  • Invasive
  • Non-Invasive

Technology Outlook (Revenue, USD Billion; 2017-2027)

  • Mass Spectrometry
  • Enzyme Immunoassays
  • Electrophoresis
  • DNA Assays

Instrument Outlook (Revenue, USD Billion; 2017-2027)

  • Ultrasonography
  • Tandem Quadrupole Detector
  • Reagent and Assay Kits
  • Hearing Screen Instruments
  • Incubator Shaker

End Users Outlook (Revenue, USD Billion; 2017-2027)

  • Hospitals
  • Diagnostic Centers
  • Maternity & Specialty Clinics

Click to access the Report Study, Read key highlights of the Report and Look at Projected Trends:

Regional Outlook (Revenue, USD Billion; 2017-2027)

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • U.K.
    • France
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • South Korea
    • Rest of APAC
  • Latin America
    • Brazil
    • Rest of LATAM
  • Middle East & Africa
    • Saudi Arabia
    • U.A.E.
    • Rest of MEA

Table of Content

Chapter 1. Methodology & Sources

1.1. Market Definition

1.2. Research Scope

1.3. Methodology

1.4. Research Sources

1.4.1. Primary

1.4.2. Secondary

1.4.3. Paid Sources

1.5. Market Estimation Technique

Chapter 2. Executive Summary

2.1. Summary Snapshot, 2020-2030

Chapter 3. Key Insights

Chapter 4. Prenatal Testing and Newborn Screening Market Segmentation & Impact Analysis

4.1. Prenatal Testing and Newborn Screening Market Material Segmentation Analysis

4.2. Industrial Outlook

4.2.1. Market indicators analysis

4.2.2. Market drivers’ analysis

4.2.3. Market restraints analysis

4.3. Technological Insights

4.4. Regulatory Framework

4.5. Porter’s Five Forces Analysis

4.6. Competitive Metric Space Analysis

4.7. Price trend Analysis

4.8. Covid-19 Impact Analysis


Take a Look at our Related Reports:

Xanthan Gum Market By Form (Liquid, Dry), By Application (Stabilizer, Thickener, Gelling Agent, Coating Material, Fat Replacer), By Industry Vertical (Food & Beverages, Pharmaceutical, Oil & Gas, Cosmetic & Personal Care), and By Region Forecast to 2028.

Lightweight Materials Market, By Product Type (Plastics, Metals, Composites, Elastomers), By Distribution Channel (Direct, Indirect), By Application (Automotive, Aerospace, Energy, Marine), and By Region Forecast to 2028.

Biorational Product Market, By Type (Insecticides, Fungicides, and Nematicides), By Source (Botanical, Microbial, and Non-Organic), By Mode of Application (Foliar Spray, Soil treatment, and Trunk Injection), and By Region Forecast to 2028.

Optically Clear Adhesive Market By Resin Type (Polyvinyl Acetate, Acrylic, Polyurethane, Epoxy, Silicone, Others), Device Structure, Substrate, Application (Mobile Phones, Monitors & Laptop, Others), By End-Use, and By Region Forecast to 2028.

Metal Foam Market By Material (Aluminum, Copper, Titanium, Zinc, Nickel), By Product (Open Cell, Closed Cell), By Application (Floating Cities, Heat Exchangers, Anti-Intrusion Bars, Energy Absorbers), By End-Use, and By Region Forecast to 2028.

Fullerene Market By Type (C60, C70, C76, Other), By Production Method (Arc Discharge Method, CVD/CCVD Process, Laser Ablation of Graphite, Others), By Shape (Nanotubes, Bucky Balls, Nano-Rods), By End-use, and By Region Forecast to 2028

About Emergen Research

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web:

Direct Line: +1 (604) 757-9756


Facebook | LinkedIn | Twitter | Blogs

Read Full Press Release@